Scott & Selber Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67M Sell
2,224
-10
-0.4% -$10.2K 0.56% 44
2026
Q1
$2.05M Sell
2,234
-9
-0.4% -$9.12K 0.53% 58
2025
Q4
$2.41M Buy
2,243
+88
+4% +$84.1K 0.6% 51
2025
Q3
$1.64M Buy
2,155
+17
+0.8% +$12.7K 0.42% 68
2025
Q2
$1.67M Buy
2,138
+18
+0.8% +$14K 0.46% 67
2025
Q1
$1.75M Hold
2,120
0.56% 61
2024
Q4
$1.64M Buy
2,120
+1
+0% +$828 0.49% 65
2024
Q3
$1.88M Sell
2,119
-15
-0.7% -$13.5K 0.58% 57
2024
Q2
$1.93M Buy
2,134
+15
+0.7% +$12K 0.62% 55
2024
Q1
$1.65M Sell
2,119
-11
-0.5% -$7.83K 0.56% 63
2023
Q4
$1.24M Sell
2,130
-6
-0.3% -$3.5K 0.47% 66
2023
Q3
$1.15M Sell
2,136
-1
-0% -$515 0.47% 67
2023
Q2
$1M Buy
2,137
+18
+0.8% +$7.55K 0.39% 78
2023
Q1
$728K Buy
2,119
+5
+0.2% +$1.69K 0.31% 90
2022
Q4
$773K Buy
2,114
+29
+1% +$10.3K 0.35% 88
2022
Q3
$674K Buy
+2,085
New +$661K 0.32% 88
2022
Q1
Sell
-3,200
Closed -$884K 108
2021
Q4
$884K Buy
+3,200
New +$811K 0.31% 87

Other funds holding LLY

Scott & Selber Inc's LLY Position: Q2 2026 in Review

Scott & Selber Inc reduced its Eli Lilly (LLY) stake by 0.45% in Q2 2026, selling an estimated $10.2K and leaving 2,224 shares worth $2.67M. The position accounts for 0.56% of the portfolio, ranked #44.

Scott & Selber Inc first reported a position in LLY in Q4 2021 and has held it in 17 quarters since. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Scott & Selber Inc held 2,224 shares of Eli Lilly worth $2.67M as of Q2 2026.
  • Scott & Selber Inc sold 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up 0.56% of Scott & Selber Inc's portfolio in Q2 2026, its #44 holding.
  • Scott & Selber Inc first reported a position in Eli Lilly in Q4 2021 and has held it in 17 quarters since.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Scott & Selber Inc's 13F filing for Q2 2026, filed 8 Jul 2026.